Wyeth Ltd(Merged)
Wyeth Ltd(Merged)
Healthcare DelistedTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
4- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.1%
- Company has been maintaining a healthy dividend payout of 144%
- Company's working capital requirements have reduced from 27.3 days to 16.7 days
Weaknesses
1- Stock is trading at 9.14 times its book value
Growth Rate
Quarterly Results
| Particulars | Sep 2011 | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 149 | 138 | 153 | 168 | 157 | 171 | 182 | 167 | 171 | 161 | 180 | 193 | 208 |
| Expenses | 106 | 110 | 102 | 119 | 120 | 140 | 138 | 142 | 152 | 141 | 141 | 155 | 161 |
| Operating Profit | 43 | 28 | 51 | 49 | 37 | 31 | 44 | 25 | 19 | 20 | 38 | 38 | 47 |
| OPM % | 29% | 20% | 33% | 29% | 24% | 18% | 24% | 15% | 11% | 12% | 21% | 20% | 23% |
| Other Income | 7 | 8 | 13 | 10 | 9 | 8 | 9 | 9 | 10 | 8 | 8 | 6 | 5 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| PBT | 48 | 34 | 63 | 58 | 45 | 38 | 52 | 34 | 28 | 27 | 45 | 43 | 51 |
| Tax % | 29% | 28% | 31% | 33% | 33% | 33% | 32% | 35% | 35% | 35% | 34% | 34% | 35% |
| Net Profit | 34 | 25 | 44 | 39 | 30 | 26 | 35 | 22 | 18 | 17 | 30 | 28 | 34 |
| EPS in Rs | 14.96 | 10.84 | 19.23 | 17.15 | 13.33 | 11.33 | 15.5 | 9.77 | 8.1 | 7.69 | 13.17 | 12.54 | 14.78 |
Profit & Loss
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 8m | Mar 2011 16m | Mar 2012 | Mar 2013 | Mar 2014 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 286 | 285 | 329 | 382 | 286 | 640 | 588 | 678 | 679 | 742 |
| Expenses | 213 | 186 | 223 | 253 | 207 | 412 | 415 | 516 | 576 | 598 |
| Operating Profit | 73 | 99 | 106 | 129 | 79 | 228 | 173 | 162 | 103 | 143 |
| OPM % | 25% | 35% | 32% | 34% | 28% | 36% | 29% | 24% | 15% | 19% |
| Other Income | 18 | 19 | 19 | 21 | 10 | 18 | 39 | 35 | 34 | 26 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 6 | 6 | 6 | 7 | 7 | 9 | 6 | 3 | 3 | 3 |
| PBT | 84 | 111 | 118 | 142 | 82 | 236 | 205 | 193 | 134 | 166 |
| Tax % | 19% | 17% | 31% | 30% | 28% | 30% | 29% | 33% | 34% | — |
| Net Profit | 68 | 92 | 81 | 100 | 59 | 165 | 145 | 130 | 88 | 109 |
| EPS in Rs | 29.83 | 40.69 | 35.89 | 43.91 | 25.99 | 72.81 | 63.74 | 57.3 | 38.73 | 48.18 |
| Div. Payout % | 84% | 74% | 84% | 74% | 77% | 30% | 28% | 30% | 375% | — |
Balance Sheet
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 |
| Reserves | 223 | 234 | 236 | 249 | 255 | 362 | 459 | 544 | 247 |
| Borrowings | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Other Liabilities | 106 | 122 | 132 | 158 | 124 | 112 | 165 | 223 | 232 |
| Total Liabilities | 354 | 381 | 393 | 432 | 404 | 499 | 649 | 792 | 504 |
| Fixed Assets | 47 | 43 | 39 | 38 | 31 | 26 | 24 | 24 | 24 |
| CWIP | 0 | 1 | 3 | 1 | 2 | 2 | 2 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 306 | 336 | 351 | 393 | 371 | 472 | 624 | 768 | 479 |
| Total Assets | 354 | 381 | 393 | 432 | 404 | 499 | 649 | 792 | 504 |
Cash Flow
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Operating | 61 | 79 | 86 | 60 | 58 | 151 | 76 | 92 | 119 |
| Investing | 11 | 14 | 13 | 14 | 10 | 12 | 31 | 32 | 29 |
| Financing | -52 | -65 | -80 | -80 | -86 | -94 | -19 | -48 | -430 |
| Net Cash Flow | 20 | 28 | 18 | -6 | -18 | 69 | 89 | 76 | -282 |
| Free Cash Flow | 64 | 78 | 81 | 57 | 56 | 145 | 79 | 92 | 116 |
| CFO/OP | 88 | 99 | 110 | 83 | 93 | 94 | 81 | 103 | 163 |
Ratios
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 25 | 25 | 23 | 25 | 19 | 34 | 24 | 27 |
| Inventory Days | 168 | 198 | 139 | 177 | 228 | 128 | 207 | 247 | 179 |
| Days Payable | 97 | 104 | 120 | 165 | 171 | 109 | 139 | 188 | 202 |
| Cash Conversion Cycle | 97 | 118 | 44 | 36 | 82 | 39 | 102 | 83 | 4 |
| Working Capital Days | 4 | -9 | -20 | 6 | 45 | 27 | 38 | 27 | 17 |
| ROCE % | — | 43% | 45% | 54% | 30% | 72% | 46% | 37% | 32% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Wyeth Ltd(Merged) insights
29 extracted metrics + investor summaries across FY06–FY14.
Documents
Frequently Asked Questions about Wyeth Ltd(Merged)
What does Wyeth Ltd(Merged) do?
Where is Wyeth Ltd(Merged) (WYETH) listed?
Which sector does Wyeth Ltd(Merged) belong to?
Company Information
Wyeth Limited is an India-based biopharmaceutical company. The company is engaged in manufacturing, marketing, trading and export of pharmaceuticals and consumer healthcare products.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/WYETH.md for Wyeth Ltd(Merged): company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.